NCT05151614View on ClinicalTrials.gov

Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection

PHASE1CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

October 30, 2021

Study Completion Date

October 30, 2021

Conditions
COVID-19 Pandemic
Interventions
DRUG

Colchicine 0.5 MG

Colchicine 0.5 mg tab 1x2 for 1 week then o.5mg tab. 1x1 for another week + the standard therapy ( total duration of colchicine 14 days).

Trial Locations (1)

Unknown

University of Baghdad, Baghdad

All Listed Sponsors
lead

University of Baghdad

OTHER

NCT05151614 - Adjuvant Use Of Colchicine With The Standard Therapy In Moderate And Severe Corona Virus Disease-19 Infection | Biotech Hunter | Biotech Hunter